# Effect of Repeated Administration of Eslicarbazepine Acetate on the Pharmacokinetics of Simvastatin in Healthy Subjects

> **NCT00987558** · PHASE1 · COMPLETED · sponsor: **Bial - Portela C S.A.** · enrollment: 30 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Eslicarbazepine acetate
- **DRUG:** Simvastatin

## Key facts

- **NCT ID:** NCT00987558
- **Lead sponsor:** Bial - Portela C S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2015-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00987558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00987558, "Effect of Repeated Administration of Eslicarbazepine Acetate on the Pharmacokinetics of Simvastatin in Healthy Subjects". Retrieved via MORVS 2026-10-12 from https://api.morvs.ai/clinical/NCT00987558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*